Company intelligence / Profile preview

Nukleus

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Nukleus is a London-based life science venture builder that specializes in identifying, funding, and scaling innovative biotech and healthcare companies. The firm partners with leading academic institutions and scientists to translate high-potential research into commercially viable startups. By providing a combination of strategic guidance, operational support, and early-stage capital, Nukleus aims to bridge the gap between laboratory discovery and clinical application. Their portfolio spans diverse areas of the life sciences, including therapeutics, diagnostics, and medical technology.

Industry: Investors

Partnerships

Octopus VenturesWellcome Trust (historical ties via leadership)

Beyond the preview

Go deeper on Nukleus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nukleus.

Explore the full profile